Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beckman releases C-reactive protein test:

This article was originally published in Clinica

Executive Summary

Beckman Coulter has launched a high-sensitivity laboratory test for helping physicians determine a patient's risk of coronary artery disease. The test, called CRPH, measures levels of C-reactive protein (CRP), a marker that is produced in the liver and released into the blood as a result of infection or injury, such as tissue damage or inflammation caused by coronary artery disease. The test is available on the Fullerton, California company's IMMAGE immunochemistry system and SYNCHRON LX20 PRO chemistry analyser.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel